The Prima photovoltaic retinal stimulation microchip, a brain-computer interface device designed to restore vision in patients with geographic atrophy, has launched commercially across 30 European countries.

Science Corporation announced the European launch of its retinal implant for patients with age-related macular degeneration.

Science Corp. Announces European Commercial Launch of PRIMA, the Only Treatment to Restore Functional Central Vision to Patients with Geographic Atrophy Caused by Age-Related…